Development News Edition
Give Feedback

BIZ--AUROBINDO PHARMA


PTI hyderabad Last Updated at 13-11-2018 14:08:20 IST India

Aurobindo Pharma has said it's

wholly-owned subsidiaryhas entered into an agreement to

acquire a product under development and related assets from

Australia-based Advent Pharmaceuticals Pty Ltd for USD 12.5

million.

"Our wholly-owned subsidiary, Aurobindo Pharma USA

Inc., USA, has entered into an agreement to acquire a product

under development and related assets from Advent

Pharmaceuticals Pty Ltd, Australia, through AuroScience Pty

Limited, Melbourne, a 100 per cent subsidiary of Aurobindo

Pharma USA Inc, USA," a regulatory filing from Aurobindo said

Monday.

Based out of Melbourne, Advent Pharmaceuticals is

engaged in developing and commercialising generic inhaled

medicines for global markets.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


add banner

LEAVE COMMENT